Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
Additional prescribing authorization matters for safe pharmacy practice in Alberta
February 24, 2026
Albertans may expect that any pharmacist they are seeing can prescribe at initial access.
Read more ➞
